PT Kalbe Farma Tbk : Company Update - Q1 2025 Unaudited Results (09-May-2025)

About this update from Pt Kalbe Farma Tbk

Company Update 1Q25 PT Kalbe Farma Tbk May 2025 Table of Content Key Updates 04 Business Strategies 08 Financial Overview 23 Appendix 1 30 Appendix 2 37 Key Updates Market Capitalization More than Half a Century of Providing Wide-Range Healthcare Solutions Corporate Overview Prescription Pharmaceuticals Indonesian integrated healthcare company with regional footprint 1966 Established, headquartered in Jakarta 1991 Listed in the Indonesia Stock Exchange Onwards The most integrated healthcare company in Southeast Asia 6% Export Middle East SEA ± 40 Countries South Africa IDR 53.2 tn ($3.2 bn) * free float * 42.01% Including treasury stocks 32.5% 28.1% Net Sales IDR 8,845 bn 1Q 2025 (unaudited) 15.4% 24.0% Consumer Health Nutritionals Distribution & Logistics * As of 31 Mar 25 Attention : This is an excerpt of the original content. To continue reading it, access the original document here .

View stock analysis, news, and events for Pt Kalbe Farma Tbk